Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EBP | Q15125 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | PDCD4 | Q53EL6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10490360 | 1.00 | EBP (0.39) | EBPSIGMAR1LMNAALDH1A1TDP1 | |
| SCHEMBL1110951 | 0.85 | ALDH1A1 (0.43) | EBPSIGMAR1ALDH1A1 | |
| SCHEMBL5972212 | 0.85 | ALDH1A1 (0.39) | EBPSIGMAR1ALDH1A1 | |
| SCHEMBL18662303 | 0.85 | EBP (0.38) | EBPSIGMAR1ALDH1A1TDP1 | |
| SCHEMBL1110980 | 0.85 | ALDH1A1 (0.43) | EBPSIGMAR1ALDH1A1 | |
| SCHEMBL2049944 | 0.85 | ALDH1A1 (0.43) | EBPSIGMAR1ALDH1A1 | |
| SCHEMBL18662315 | 0.85 | ALDH1A1 (0.43) | EBPSIGMAR1ALDH1A1 | |
| SCHEMBL29593 | 0.81 | ALDH1A1 (0.48) | LMNAALDH1A1TDP1PDCD4 | |
| SCHEMBL3245975 | 0.81 | ALDH1A1 (0.48) | LMNAALDH1A1TDP1PDCD4 | |
| SCHEMBL3241159 | 0.81 | ALDH1A1 (0.48) | LMNAALDH1A1TDP1PDCD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230398131-A1 | PHARMACEUTICAL SPRAY COMPOSITION COMPRISING A VITAMIN D ANALOGUE AND CORTICOSTEROID | LEO PHARMA AS (DK) | 2023-12-14 | — | — | US | claimed |
| CN-114555055-A | Anhydrous pharmaceutical composition for the maintenance treatment of psoriasis | 利奥制药有限公司 | 2022-05-27 | — | — | CN | claimed |
| US-20210128588-A1 | PHARMACEUTICAL SPRAY COMPOSITION COMPRISING A VITAMIN D ANALOGUE AND CORTICOSTEROID | LEO PHARMA A/S | 2021-05-06 | — | — | US | claimed |
| WO-2021069496-A1 | AN ANHYDROUS PHARMACEUTICAL COMPOSITION FOR MAINTENANCE TREATMENT OF PSORIASIS | LEO PHARMA A/S (DK) | 2021-04-15 | — | — | WO | claimed |
| US-10716799-B2 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | LEO PHARMA A/S (DK) | 2020-07-21 | — | — | US | claimed |
| US-10682364-B2 | Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid | LEO PHARMA A/S (DK) | 2020-06-16 | — | — | US | claimed |
| US-10660908-B2 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | LEO PHARMA A/S (DK) | 2020-05-26 | — | — | US | claimed |
| US-10617698-B2 | Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid | LEO PHARMA A/S (DK) | 2020-04-14 | — | — | US | claimed |
| US-20190015430-A1 | PHARMACEUTICAL SPRAY COMPOSITION COMPRISING A VITAMIN D ANALOGUE AND A CORTICOSTEROID | LEO PHARMA A/S (DK) | 2019-01-17 | — | — | US | claimed |
| US-10130640-B2 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | LEO PHARMA A/S (DK) | 2018-11-20 | — | — | US | claimed |
| WO-2011076209-A2 | PHARMACEUTICAL COMPOSITION COMPRISING SOLVENT MIXTURE AND A VITAMIN D DERIVATIVE OR ANALOGUE | LEO PHARMA A/S (DK) | 2011-06-30 | — | — | WO | claimed |
| CN-101987070-A | Oil-in-water microemulsion with high oil-loading quantity | EVONIK DEGUSSA CHINA CO LTD | 2011-03-23 | — | — | CN | claimed |
| CN-101987069-A | Thermally stable oil-in-water microemulsion | EVONIK DEGUSSA CHINA CO LTD | 2011-03-23 | — | — | CN | claimed |
| US-20110028424-A1 | OIL-IN-WATER MICROEMULSION CARRYING LARGE AMOUNT OF OIL | EVONIK GOLDSCHMIDT GMBH (DE) | 2011-02-03 | — | — | US | claimed |
| EP-2279724-A2 | Oil-in-water microemulsion carrying large amount of oil | Evonik Goldschmidt GmbH (DE) | 2011-02-02 | — | — | EP | claimed |
| US-7622844-B1 | Metal fiber brush interface conditioning | HIPERCON, LLC (US) | 2009-11-24 | — | — | US | claimed |
| EP-1255528-B1 | LOW TACK COSMETIC COMPOSITION STICKS | COLGATE PALMOLIVE CO (US) | 2005-11-16 | — | — | EP | claimed |
| EP-1255528-A1 | LOW TACK COSMETIC COMPOSITION STICKS | Colgate-Palmolive Company (US) | 2002-11-13 | — | — | EP | claimed |
| WO-2001060329-A1 | LOW TACK COSMETIC COMPOSITION STICKS | COLGATE-PALMOLIVE COMPANY (US) | 2001-08-23 | — | — | WO | claimed |
| US-6180125-B1 | AS ANTIPERSPIRANT | COLGATE-PALMOLIVE COMPANY | 2001-01-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230398131-A1 | PHARMACEUTICAL SPRAY COMPOSITION COMPRISING A VITAMIN D ANALOGUE AND CORTICOSTEROID | CYP24A1, CYP2R1, VDR | EBP 53/4885SIGMAR1 4511/4885LMNA 3491/4885 |
| US-10716799-B2 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | CYP24A1, CYP2R1, VDR | EBP 54/4885SIGMAR1 4515/4885LMNA 3007/4885 |
| US-20190015430-A1 | PHARMACEUTICAL SPRAY COMPOSITION COMPRISING A VITAMIN D ANALOGUE AND A CORTICOSTEROID | CYP24A1, CYP2R1, VDR | EBP 54/4885SIGMAR1 4515/4885LMNA 3007/4885 |
| US-20210128588-A1 | PHARMACEUTICAL SPRAY COMPOSITION COMPRISING A VITAMIN D ANALOGUE AND CORTICOSTEROID | CYP24A1, CYP2R1, VDR | EBP 53/4885SIGMAR1 4511/4885LMNA 3491/4885 |
| US-10660908-B2 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | CYP24A1, CYP2R1, VDR | EBP 54/4885SIGMAR1 4515/4885LMNA 3007/4885 |
| US-10130640-B2 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | CYP24A1, CYP2R1, VDR | EBP 49/4885SIGMAR1 4517/4885LMNA 3046/4885 |
| US-10617698-B2 | Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid | CYP24A1, CYP2R1, VDR | EBP 55/4885SIGMAR1 4643/4885LMNA 2948/4885 |
| US-10682364-B2 | Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid | CYP24A1, CYP2R1, VDR | EBP 66/4885SIGMAR1 4508/4885LMNA 3153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.